Timing of hormone therapy and its association with cardiovascular risk and metabolic parameters in 4-vinylcyclohexene diepoxide-induced primary ovarian insufficiency mouse model

Hyun Joo Leea Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of KoreaView further author information

Min Jung Parkb The Korea Institute for Public Sperm Bank, Busan, Republic of KoreaView further author information

Jeong-Doo Heoc Korea Institute of Toxicology, Gyeongnam Branch Institute, Jinju, Gyeongsangnam-do, Republic of KoreaView further author information

Bo Sun Joob The Korea Institute for Public Sperm Bank, Busan, Republic of KoreaView further author information

Jong Kil Jooa Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of KoreaCorrespondence[email protected]
View further author information

Timing of hormone therapy and its association with cardiovascular risk and metabolic parameters in 4-vinylcyclohexene diepoxide-induced primary ovarian insufficiency mouse model

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Timing of hormone therapy and its association with cardiovascular risk and metabolic parameters in 4-vinylcyclohexene diepoxide-induced primary ovarian insufficiency mouse model

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date